SCHEMBL21886454

SCHEMBL21886454

COCCOc1ccc(-c2cc(=O)c3cccc(Cl)c3o2)cc1Cl

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ABCB1 P08183 2/20 0.47
▸ ABCC1 P33527 2/20 0.47
▸ ABCG2 Q9UNQ0 2/20 0.47
▸ CSNK2A2 P19784 3/20 0.45
▸ CSNK2B P67870 3/20 0.45
▸ CSNK2A1 P68400 3/20 0.45
▸ CYP1A1 P04798 2/20 0.45
▸ CYP1A2 P05177 2/20 0.45
▸ CYP1B1 Q16678 2/20 0.45
▸ TERT O14746 4/20 0.44
▸ KDM4E B2RXH2 1/20 0.43
▸ MEN1 O00255 1/20 0.43
▸ ALDH1A1 P00352 1/20 0.43
▸ GLA P06280 1/20 0.43
▸ CYP3A4 P08684 1/20 0.43
▸ MAPT P10636 1/20 0.43
▸ THRB P10828 1/20 0.43
▸ HPGD P15428 1/20 0.43
▸ MAPK1 P28482 1/20 0.43
▸ KMT2A Q03164 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21886510 0.90 ABCC1 (0.47) ABCB1ABCC1ABCG2CSNK2A2CSNK2B
SCHEMBL21865746 0.89 CSNK2A2 (0.44) ABCB1ABCC1ABCG2CSNK2A2CSNK2B
SCHEMBL21801245 0.86 ABCB1 (0.58) ABCB1ABCC1ABCG2CSNK2A2CSNK2B
SCHEMBL30744133 0.86 ABCB1 (0.58) ABCB1ABCC1ABCG2CSNK2A2CSNK2B
SCHEMBL30629641 0.80 SIGMAR1 (0.41) CSNK2A2CSNK2BCSNK2A1
SCHEMBL21801155 0.80 SIGMAR1 (0.41) CSNK2A2CSNK2BCSNK2A1
SCHEMBL21801157 0.80 SIGMAR1 (0.41) CSNK2A2CSNK2BCSNK2A1
SCHEMBL22231441 0.79 ABCB1 (0.52) ABCB1ABCC1ABCG2CSNK2A2CSNK2B
SCHEMBL21865645 0.79 CYP1B1 (0.46) ABCB1ABCC1ABCG2CSNK2A2CSNK2B
SCHEMBL21801140 0.78 ABCC1 (0.57) ABCB1ABCC1ABCG2CSNK2A2CSNK2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020052774-A1 FLAVONE DERIVATIVES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS DISEASE F. HOFFMANN-LA ROCHE AG (CH) 2020-03-19 — — WO disclosed
Send feedback